Evidence map›Paper›PMID 37176483›Full record

ArticleMaterials (Basel, Switzerland)2023

Determination of the Effect of Wastewater on the Biological Activity of Mixtures of Fluoxetine and Its Metabolite Norfluoxetine with Nalidixic and Caffeic Acids with Use of

Marzena Matejczyk, Piotr Ofman, Józefa Wiater, Renata Świsłocka, Paweł Kondzior, Włodzimierz Lewandowski

Open access · goldAbstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Marzena MatejczykFaculty of Civil Engineering and Environmental Sciences, Department of Chemistry, Biology and Biotechnology, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.
Piotr OfmanDepartment of Technology in Environmental Engineering, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.ORCID 0000-0002-0061-8025
Józefa WiaterDepartment of Agri-Food Engineering and Environmental Management, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.
Renata ŚwisłockaFaculty of Civil Engineering and Environmental Sciences, Department of Chemistry, Biology and Biotechnology, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.ORCID 0000-0001-7034-9126
Paweł KondziorFaculty of Civil Engineering and Environmental Sciences, Department of Chemistry, Biology and Biotechnology, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.ORCID 0000-0002-4991-5813
Włodzimierz LewandowskiFaculty of Civil Engineering and Environmental Sciences, Department of Chemistry, Biology and Biotechnology, Bialystok University of Technology, Wiejska 45E Street, 15-351 Bialystok, Poland.
Bialystok University of Technology · PL

Funding

National Science Centre, Poland 2018/29/NZ9/01997
6 · The paper itself

Abstract

In the present work, the conducted research concerned the determination of the toxicity and oxidative stress generation of the antidepressant fluoxetine (FLU), its metabolite nor-fluoxetine (Nor-FLU), the antibiotic nalidixic acid (NA), caffeic acid (CA) and their mixtures in three different environments: microbial medium (MM), raw wastewaters (RW) and treated wastewaters (TW). We evaluated the following parameters:

Indexed as

caffeic acidfluoxetinemicrobial bioindicatornalidixic acidtoxicitywastewaters

Identifiers

PMID37176483
PMCPMC10180322
OpenAlexW4376631012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.